Dawn Sherman

Chief Executive Officer and Board Member

Dawn brings a wealth of strategic leadership experience to ProPharma Group. She has worked extensively within the healthcare industry, holding roles such as President, COO, and Global Managing Director for several global healthcare companies.

Prior to becoming CEO of ProPharma Group, Dawn was President of EnvisionRxOptions, a national, full-service pharmacy benefit management company. Dawn was responsible for EnvisionRx, MedTrakRx, EnvisionPharmacies, Envision Savings, and LakerSoftware, as well as several functional areas such as strategy, product development, pricing, client analytics, IT, manufacturer and provider relations, marketing, and customer service operations. Dawn also led all integration efforts with Rite Aid since the acquisition of EnvisionRxOptions by Rite Aid in June 2015.

Prior to joining EnvisionRxOptions, Dawn served as Chief Operating Officer (COO) for Teva Pharmaceuticals Europe B.V., where she had oversight of commercial operations across 36 countries as well as global responsibility for patient solutions. Dawn’s broad focus included strategy and innovation for patient support, commercial effectiveness, market access, business insights and intelligence, and government affairs. Additionally, Dawn had responsibility for corporate communications and driving organizational efficiency and effectiveness.

Before joining Teva, Dawn was Chief Operating Officer of Medco International, B.V., where she focused on delivering innovative, integrated clinical services to improve efficiency across the European healthcare system. Before relocating to the Netherlands, Dawn held other roles during her tenure with Medco Health Solutions, Inc., such as Senior Vice President and Chief Operating Officer for Medco’s international strategy and operations, where she led activities related to integrating and operationalizing international business opportunities within Medco.

Prior to Medco, Dawn was Global Managing Director for Hay Group Insight, Hay Group’s survey research division. In this role, she worked with executive management teams and board members from Fortune 100 companies in a wide spectrum of industries with a focus on improving organizational and operational effectiveness.

Dawn completed her undergraduate work at Miami University with degrees in Psychology and Sociology and received her master’s degree in Sociology from New York University.

Company Blog

January 15, 2020
Phase Appropriate Controls and GMPs in Cell and Gene Therapy
Compliance expert Benjamin Frey discusses the development of quality systems and controls for investigational… Read More
January 2, 2020
How to Safely Launch Medical Cannabis Products in Germany
Our expert's advice on how to navigate through the main challenges confronting you when… Read More
December 11, 2019
Five Steps Toward a Mature Data Integrity Culture
How can your company demonstrate the trustworthiness of GxP data as expected by regulators?… Read More
More Articles

UPCOMING Events

January 27, 2020
Pharmacovigilance and Risk Management Strategies Conference
DIA’s Pharmacovigilance and Risk Management Strategies Conference provides the foundation for strong str... Read More
February 18, 2020
SCOPE Summit 2020
Celebrating its 11th successful year, SCOPE Summit 2020 takes place February 18-21 in Orlando, FL. Over the co... Read More
March 23, 2020
DIA Medical Affairs and Scientific Communications Forum
DIA’s Medical Affairs and Scientific Communications Forum is designed for medical affairs professionals, b... Read More
All Events
Contact Us